ArticleMolecules (Basel, Switzerland)2026
(
Ganga Reddy Velma, Srinivasa Reddy Telukutla, Jayaram Vankudoth, Ajmer Singh Grewal, Steven Privér, Poornachandra Yedla, Ravikumar Akunuri, Donald Wlodkowic, Srihari Pabbaraja, Suresh K Bhargava and 2 more
Abstract read
In one paragraphArticle in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Ganga Reddy VelmaCentre for Advanced Materials & Industrial Chemistry (CAMIC), School of Science, RMIT University, GPO BOX 2476, Melbourne, VIC 3001, Australia.ORCID 0000-0001-5054-2519 Srinivasa Reddy TelukutlaCentre for Advanced Materials & Industrial Chemistry (CAMIC), School of Science, RMIT University, GPO BOX 2476, Melbourne, VIC 3001, Australia.ORCID 0000-0002-2806-4300 Jayaram VankudothDepartment of Biochemistry, Chemical Synthesis Core Facility, Albert Einstein College of Medicine, Gruss MRRC-314, Bronx, NY 10461, USA.ORCID 0000-0003-0419-6525 Ajmer Singh GrewalDepartment of Pharmaceutical Sciences, Guru Gobind Singh College of Pharmacy, Yamuna Nagar 135 001, India.ORCID 0000-0002-2418-9616 Steven PrivérCentre for Advanced Materials & Industrial Chemistry (CAMIC), School of Science, RMIT University, GPO BOX 2476, Melbourne, VIC 3001, Australia.
Poornachandra YedlaDepartment of Organic Synthesis & Process Chemistry, CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad 500 007, India.
Ravikumar AkunuriDepartment of Organic Synthesis & Process Chemistry, CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad 500 007, India.ORCID 0000-0003-4898-5753 Donald WlodkowicPhenomics Laboratory, School of Science, RMIT University, Plenty Road, P.O. Box 71, Bundoora, VIC 3083, Australia.ORCID 0000-0002-0780-3362 Srihari PabbarajaAcademy of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, 2-Rafi Marg, New Delhi 110 001, India.ORCID 0000-0002-1708-6539 Suresh K BhargavaCentre for Advanced Materials & Industrial Chemistry (CAMIC), School of Science, RMIT University, GPO BOX 2476, Melbourne, VIC 3001, Australia.ORCID 0000-0002-3127-8166 Magdalena PlebanskiAccelerator for Translational Research in Clinical Trials (ATRACT) Centre, School of Health and Biomedical Sciences, STEM College, RMIT University, Melbourne, VIC 3083, Australia.ORCID 0000-0001-6889-3667 Ahmed KamalAcademy of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, 2-Rafi Marg, New Delhi 110 001, India.ORCID 0000-0002-4107-1775 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Pharmacophore hybridization is a well-established strategy for developing novel anticancer agents with improved biological profiles. In this study, a new series of (
Indexed as
Angiogenesis InhibitorsPicolinic AcidsProtein Kinase InhibitorsProto-Oncogene Proteins B-rafVascular Endothelial Growth Factor Receptor-2AnimalsAntineoplastic AgentsApoptosisCell Line, TumorCell ProliferationHEK293 CellsHep G2 CellsHumansHuman Umbilical Vein Endothelial CellsMolecular Docking SimulationSorafenibAngiogenesis InhibitorsAntineoplastic AgentsKDR protein, humanPicolinic AcidsProtein Kinase InhibitorsProto-Oncogene Proteins B-rafSorafenibVascular Endothelial Growth Factor Receptor-2angiogenesisanticancerapoptosisb-Raf inhibitorsVEGFR-2 inhibitorszebrafish
Identifiers
PMID42197311
PMCPMC13209728
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390